Advances and issues in bronchopulmonary dysplasia.
Zimmerman
J J
JJ
Department of Pediatrics, University of Wisconsin, Madison.
Farrell
P M
PM
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001469:Barotrauma / Q000150:complications; D001993:Bronchodilator Agents / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D007049:Iatrogenic Disease; D007231:Infant, Newborn; D010100:Oxygen / Q000009:adverse effects; D010289:Parenteral Nutrition, Total; D011014:Pneumonia / Q000150:complications; D011379:Prognosis; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000009:adverse effects; D012307:Risk Factors; D014801:Vitamin A / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D011663:Pulmonary Surfactants; D014801:Vitamin A; D014810:Vitamin E; D010100:Oxygen